.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Julphar
Federal Trade Commission
Medtronic
Harvard Business School
Farmers Insurance
Boehringer Ingelheim
US Department of Justice
Deloitte
Novartis

Generated: July 25, 2017

DrugPatentWatch Database Preview

Pancrelipase (amylase;lipase;protease) - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for pancrelipase (amylase;lipase;protease) and what is the scope of pancrelipase (amylase;lipase;protease) patent protection?

Pancrelipase (amylase;lipase;protease)
is the generic ingredient in seven branded drugs marketed by Forest Labs Inc, Janssen Pharms, Abbvie, Digestive Care Inc, and Organon Usa Inc, and is included in seven NDAs. There are nine patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Pancrelipase (amylase;lipase;protease) has seventy-five patent family members in twenty-nine countries.

There are six drug master file entries for pancrelipase (amylase;lipase;protease). Eight suppliers are listed for this compound.

Summary for Generic Name: pancrelipase (amylase;lipase;protease)

Tradenames:7
Patents:9
Applicants:5
NDAs:7
Drug Master File Entries: see list6
Suppliers / Packagers: see list8
Clinical Trials: see list794
Drug Prices:see low prices
DailyMed Link:pancrelipase (amylase;lipase;protease) at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie
CREON
pancrelipase (amylase;lipase;protease)
CAPSULE, DELAYED RELEASE;ORAL020725-005Mar 14, 2013RXYesNo► Subscribe► Subscribe► Subscribe
Forest Labs Inc
ZENPEP
pancrelipase (amylase;lipase;protease)
CAPSULE, DELAYED RELEASE;ORAL022210-003Aug 27, 2009RXYesNo► Subscribe► Subscribe ► Subscribe
Forest Labs Inc
ZENPEP
pancrelipase (amylase;lipase;protease)
CAPSULE, DELAYED RELEASE;ORAL022210-007Mar 25, 2014RXYesNo► Subscribe► SubscribeY ► Subscribe
Forest Labs Inc
ZENPEP
pancrelipase (amylase;lipase;protease)
CAPSULE, DELAYED RELEASE;ORAL022210-004Aug 27, 2009RXYesNo► Subscribe► SubscribeY ► Subscribe
Forest Labs Inc
ZENPEP
pancrelipase (amylase;lipase;protease)
CAPSULE, DELAYED RELEASE;ORAL022210-001Aug 27, 2009RXYesNo► Subscribe► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: pancrelipase (amylase;lipase;protease)

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,293,229Methods of producing stable pancreatic enzyme compositions► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: pancrelipase (amylase;lipase;protease)

Country Document Number Estimated Expiration
Spain2320174► Subscribe
Portugal1931316► Subscribe
Spain2560527► Subscribe
Australia2008218595► Subscribe
Ukraine92030► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Fish and Richardson
Healthtrust
US Department of Justice
Accenture
Medtronic
AstraZeneca
Chinese Patent Office
Harvard Business School
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot